These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19156522)

  • 21. MELD and other predictors of survival after liver transplantation.
    Brandão A; Fuchs SC; Gleisner AL; Marroni C; Zanotelli ML; Cantisani G;
    Clin Transplant; 2009; 23(2):220-7. PubMed ID: 19210688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
    Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
    Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States.
    Berry K; Ioannou GN
    Gastroenterology; 2015 Sep; 149(3):669-80; quiz e15-6. PubMed ID: 26021233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liberal policy in living donor liver transplantation for hepatocellular carcinoma: lessons learned.
    Sotiropoulos GC; Lang H; Sgourakis G; Nadalin S; Molmenti EP; Radtke A; Paul A; Beckebaum S; Saner FH; Baba HA; Gerken G; Malagó M; Broelsch CE
    Dig Dis Sci; 2009 Feb; 54(2):377-84. PubMed ID: 18594985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COMPARATIVE STUDY ON LIVER TRANSPLANTATION WITH AND WITHOUT HEPATOCELLULAR CARCINOMA WITH CIRRHOSIS: ANALYSIS OF MELD, WAITING TIME AND SURVIVAL.
    Freitas AC; Shiguihara RS; Monteiro RT; Pazeto TL; Coelho JC
    Arq Bras Cir Dig; 2016 Mar; 29(1):21-5. PubMed ID: 27120734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting recurrence and survival after living donor liver transplantation for hepatocellular carcinoma.
    Abdel-Wahab M; Sultan AM; Fathy OM; Salah T; Elshobary MM; Elghawalby NA; Yassen AM; Elsarraf WM; Elsaadany MF; Zalatah K
    Hepatogastroenterology; 2013; 60(128):1847-53. PubMed ID: 24719918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is it Time to Abandon the Milan Criteria?: Results of a Bicoastal US Collaboration to Redefine Hepatocellular Carcinoma Liver Transplantation Selection Policies.
    Halazun KJ; Tabrizian P; Najjar M; Florman S; Schwartz M; Michelassi F; Samstein B; Brown RS; Emond JC; Busuttil RW; Agopian VG
    Ann Surg; 2018 Oct; 268(4):690-699. PubMed ID: 30048307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors of hepatocellular carcinoma recurrence after liver transplantation: accuracy of the alpha-fetoprotein model in a single-center experience.
    Varona MA; Soriano A; Aguirre-Jaime A; Garrido S; Oton E; Diaz D; Portero J; Bravo P; Barrera MA; Perera A
    Transplant Proc; 2015; 47(1):84-9. PubMed ID: 25645778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver transplantation should be offered to patients with small solitary hepatocellular carcinoma and a positive serum alpha fetoprotein rather than resection.
    Graham JA; Melancon JK; Shetty K; Johnson LB
    Am J Surg; 2013 Apr; 205(4):374-80. PubMed ID: 23395581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The survival benefit of liver transplantation in hepatocellular carcinoma patients.
    Cillo U; Vitale A; Volk ML; Frigo AC; Grigoletto F; Brolese A; Zanus G; D'Amico F; Farinati F; Burra P; Russo F; Angeli P; D'Amico DF
    Dig Liver Dis; 2010 Sep; 42(9):642-9. PubMed ID: 20381438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of HCC-MELD Score in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Guerrini GP; Pinelli D; Marini E; Corno V; Guizzetti M; Zambelli M; Aluffi A; Lincini L; Fagiuoli S; Lucianetti A; Colledan M
    Prog Transplant; 2018 Mar; 28(1):63-69. PubMed ID: 29251164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survivals after liver transplantation for hepatocellular carcinoma: Granular data for a better allocation process?
    Lai Q; Rossi M
    Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):374-375. PubMed ID: 29866607
    [No Abstract]   [Full Text] [Related]  

  • 33. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
    J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. α-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation.
    Zhang Q; Shang L; Zang Y; Chen X; Zhang L; Wang Y; Wang L; Liu Y; Mao S; Shen Z
    Eur J Gastroenterol Hepatol; 2014 May; 26(5):544-52. PubMed ID: 24614696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addition of alfa fetoprotein to traditional criteria for hepatocellular carcinoma improves selection accuracy in liver transplantation.
    Sternby Eilard M; Holmberg E; Naredi P; Söderdahl G; Rizell M
    Scand J Gastroenterol; 2018 Aug; 53(8):976-983. PubMed ID: 30169974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanding transplant criteria for hepatocellular carcinoma: small steps down a long road.
    Sanchez W
    Hepatology; 2009 Mar; 49(3):724-5. PubMed ID: 19241486
    [No Abstract]   [Full Text] [Related]  

  • 37. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria.
    Duvoux C; Roudot-Thoraval F; Decaens T; Pessione F; Badran H; Piardi T; Francoz C; Compagnon P; Vanlemmens C; Dumortier J; Dharancy S; Gugenheim J; Bernard PH; Adam R; Radenne S; Muscari F; Conti F; Hardwigsen J; Pageaux GP; Chazouillères O; Salame E; Hilleret MN; Lebray P; Abergel A; Debette-Gratien M; Kluger MD; Mallat A; Azoulay D; Cherqui D;
    Gastroenterology; 2012 Oct; 143(4):986-94.e3; quiz e14-5. PubMed ID: 22750200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival Benefit of Liver Transplantation Versus Resection for Hepatocellular Carcinoma: Impact of MELD Score.
    Vitale A; Huo TL; Cucchetti A; Lee YH; Volk M; Frigo AC; Cescon M; Tuci F; Pinna AD; Cillo U
    Ann Surg Oncol; 2015; 22(6):1901-7. PubMed ID: 25234023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient Selection by Tumor Markers in Liver Transplantation for Advanced Hepatocellular Carcinoma.
    Lee HW; Song GW; Lee SG; Kim JM; Joh JW; Han DH; Kim SI; Kim SH; Kim DS; Cho JY; Suh KS
    Liver Transpl; 2018 Sep; 24(9):1243-1251. PubMed ID: 29575509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.